Inventor
FANG LAWRENCE Y
US11 patents
⚠️ This page may combine multiple inventors who share the name “FANG LAWRENCE Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELAN PHARM INC
5 patentsUS7034182B2Apr 25, 2006
Compounds to treat Alzheimer's disease
ELAN PHARM INC37 citations92
US7214715B2May 8, 2007
Compounds to treat Alzheimer's disease
ELAN PHARM INC18 citations83
US7030239B2Apr 18, 2006
Compounds to treat Alzheimer's disease
ELAN PHARM INC13 citations83
US6737420B2May 18, 2004
Compounds to treat Alzheimer's disease
ELAN PHARM INC14 citations83
US7119085B2Oct 10, 2006
Methods to treat alzheimer's disease
ELAN PHARM INC2 citations61
ATHENA NEUROSCIENCES INC
5 patentsUS6117901ASep 12, 2000
N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
ATHENA NEUROSCIENCES INC18 citations92
US6767918B2Jul 27, 2004
N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC0 citations52
US6642261B2Nov 4, 2003
N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC0 citations52
US6333351B1Dec 25, 2001
N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC1 citations52
US6313152B1Nov 6, 2001
N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC0 citations52